News | August 03, 2025
Beta-HPV can directly cause skin cancer in immunocompromised people
cSCC is one of the most common cancers in the U.S. and globally
cSCC is one of the most common cancers in the U.S. and globally
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Supply increase to help meet growing global demand
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
INOVIO remains confident in the therapy’s benefits and intends to meet with the FDA to discuss maintaining eligibility under this pathway
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
Based on these promising results, Johnson & Johnson plans to move the program into a Phase 3 trial to further investigate subcutaneous amivantamab
Subscribe To Our Newsletter & Stay Updated
